Cranbury, NJ, United States of America

Shanming Kuang

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Bantam Pharmaceutical, LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shanming Kuang. Retrieved from https://idiyas.com/inventor/shanming-kuang-1ja2f1el

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shanming Kuang

Introduction

Shanming Kuang is an accomplished inventor based in Cranbury, NJ, known for his contributions to the field of pharmaceuticals. He holds a patent that showcases his innovative approach to drug development, particularly in the area of crystalline polymorphs.

Latest Patents

Shanming Kuang's notable patent is titled "Crystalline polymorphs of a 1-thiazol-2-yl-pyrazole-5-carboxylic acid derivative." This patent relates to crystalline polymorphs of a thiazolylpyrazole derivative, pharmaceutical compositions that include these polymorphs, and methods for utilizing them in various applications.

Career Highlights

Throughout his career, Shanming has demonstrated a strong commitment to advancing pharmaceutical science. His work has led to significant developments in the understanding and application of crystalline forms of compounds, which can greatly influence the efficacy and stability of medications.

Collaborations

Shanming has collaborated with esteemed colleagues, including Alan B. Cooper and Zheqiong Wu, to further enhance the research and development of pharmaceutical compositions.

Conclusion

Shanming Kuang's innovative work in the field of pharmaceuticals, particularly through his patent on crystalline polymorphs, highlights his significant contributions to drug development. His collaborations and career achievements reflect his dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…